No description
-
2001 (v1)PublicationUploaded on: April 14, 2023
-
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2009 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1999 (v1)Publication
No description
Uploaded on: December 5, 2022 -
2001 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2004 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2000 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2008 (v1)Publication
OBJECTIVE AND PATIENTS: Twenty-four pituitary adenomas from acromegalic patients (13 females, 11 males; age range 19-65 yr) were characterized for somatostatin receptor subtype 2A (sst(2A)), dopamine D(2) receptor (D(2)R), GH, and prolactin (PRL) expression by immunohistochemistry, and results correlated with the in vitro and in vivo hormone...
Uploaded on: April 14, 2023 -
1999 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2002 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2008 (v1)Publication
Dopamine D2 and somatostatin receptors (sstrs) were reported to affect non-functioning pituitary adenoma (NFPA) proliferation in vitro. However, the reported results differ according to the experimental conditions used. We established an experimental protocol allowing reproducible evaluation of NFPA cell proliferation in vitro, to test and...
Uploaded on: March 31, 2023